Get 40% Off
📈 Free Gift Friday: Instantly Copy Legendary Investors' PortfoliosCopy for Free

Valiant Laboratories sets IPO price range, aims to raise ₹152.46 crore

EditorAmbhini Aishwarya
Published 09/22/2023, 07:07 AM
© Reuters.

Mumbai-based pharmaceutical company, Valiant Laboratories, announced on Friday that it has set the price range for its initial public offering (IPO) at ₹133-140 per share. The subscription period is set to commence on September 27, with the firm aiming to generate 152.46 crore (INR100 crore = $12 million) from the IPO if shares are sold at the upper price band.

The IPO consists entirely of a fresh issue of 1.09 crore (10.9 million) equity shares by the company. There is no offer-for-sale portion included in this public issue. Investors have the option to bid for a minimum of 105 shares, and in multiples of 105 thereafter.

For retail investors, the minimum investment is set at 14,700, equivalent to 105 shares, while the maximum limit is 1,91,100 for 1,365 shares. High-net-worth individuals can invest a minimum of 2,05,800 and a maximum of 9,99,600 at the upper price band.

Valiant Laboratories specializes in active pharmaceutical ingredients (API) and bulk drug manufacturing with a focus on Paracetamol. Dhanvallabh Ventures LLP holds a majority stake of 62.5% in the company. Promoters Shantilal Shivji Vora and Santosh Shantilal Vora each hold a stake of 10.01%. Valiant Organics, listed on BSE and NSE, holds a controlling stake of 73.15% in Dhanvallabh Ventures LLP.

The proceeds raised from the IPO will be used to establish a manufacturing facility for specialty chemicals in Bharuch, Gujarat. This facility will be owned by Valiant's subsidiary, Valiant Advanced Sciences. The remaining funds from the fresh issue will be allocated towards working capital requirements and general corporate purposes.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company will open its public issue anchor book for one day on September 26, with the offer closing on October 3. This IPO is expected to be the last in a series of 13 public issues for the current month, which included companies such as Manoj Vaibhav Gems N Jewellers, Sai Silks (Kalamandir), Signature Global, Yatra Online, Zaggle Prepaid Ocean Services, SAMHI Hotels, RR Kabel, EMS, Jupiter Life Line Hospitals, and Ratnaveer Precision Engineering.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.